Skip to main content
Rodolfo Galindo, MD, Endocrinology, Miami, FL

Rodolfo Galindo MD

Diabetes, Obesity


Associate Professor

Join to View Full Profile
  • 1400 NW 10th AveSuite 805Miami, FL 33136

  • Phone+1 305-243-7500

Dr. Galindo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Rodolfo Galindo is an endocrinologist in Miami, Fl and is affiliated with University of Miami and Jackson Memorial Hospital. He received his medical degree from Instituto Superior de Ciencias Médicas de La Habana. He specializes in diabetes and obesity. He is an experienced clinical trialist and international faculty and speaker. Member of international guidelines and organizing committee of international conferences.

Education & Training

  • Jacobi Medical Center/Albert Einstein College of Medicine
    Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 2010 - 2013
  • Instituto Superior de Ciencias Médicas de la Habana
    Instituto Superior de Ciencias Médicas de la HabanaClass of 2005

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - 2027
  • GA State Medical License
    GA State Medical License 2017 - 2022
  • NY State Medical License
    NY State Medical License 2013 - 2018
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology and Metabolism
    American Board of Internal Medicine Endocrinology and Metabolism
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • ‘Stunning’ Twincretin Beats Semaglutide for A1c, Weight Reduction in T2D
    ‘Stunning’ Twincretin Beats Semaglutide for A1c, Weight Reduction in T2DJune 26th, 2021
  • Unmanaged Diabetes, High Blood Glucose Tied to COVID-19 Severity
    Unmanaged Diabetes, High Blood Glucose Tied to COVID-19 SeverityJune 26th, 2021
  • Dexcom CGM Plays Starring Role at 81st Scientific Sessions of the American Diabetes Association
    Dexcom CGM Plays Starring Role at 81st Scientific Sessions of the American Diabetes AssociationJune 25th, 2021
  • Join now to see all

Grant Support

  • Pharmaco-epidemiology of diabetes in patients with end-stage kidney diseaseUNIVERSITY OF MIAMI SCHOOL OF MEDICINE2024–2025
  • Pharmaco-epidemiology of diabetes in patients with end-stage kidney diseaseUNIVERSITY OF MIAMI SCHOOL OF MEDICINE2024–2025
  • Use of Continuous Glucose Monitoring (CGM) in End-Stage Renal Disease(ESRD) Patients with Type 2 DiabetesUNIVERSITY OF MIAMI SCHOOL OF MEDICINE2020–2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: